Cardiometabolic Risk in Children With Type 1 Diabetes.
Completed
- Conditions
- Type1 Diabetes MellitusMetabolic Complication
- Registration Number
- NCT03544541
- Lead Sponsor
- University of Ljubljana, Faculty of Medicine
- Brief Summary
To access the relationship between metabolic control of children and adolescents with type 1 diabetes and cardiometabolic risk through noninvasive imaging modalities to assess the early vasculature changes.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
- Type 1 diabetes for more than 0.5 year
- Age ≥ 10 years up to 25 years (inclusive)
- The subject/carer is willing to follow study specific instructions
Exclusion Criteria
- Youth with maturity-onset diabetes of the young, hybrid, other, or missing type
- Any significant diseases / conditions including psychiatric disorders and substance abuse that in the opinion of the investigator is likely to affect the subject's ability to complete the study
- Current use of the following medications: medications that are used to lower blood glucose such as Pramlintide, Metformin and GLP-1 analogs. Beta blockers, glucocorticoids and other medications, which in the judgment of the investigator would be a contraindication to participation in the study (Anticoagulant therapy e.g. Plavix, LMW heparin, Coumadin, Immunosuppressant therapy)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Carotid Intima-Media Thickness 24 months Non-invasive (Doppler Ultrasound) measurement of Carotid Intima-Media Thickness
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
UMC-University Children's Hospital
🇸🇮Ljubljana, Slovenia